Join Now

Category Archives: BioUtah News

Improving Women’s Health: MobileODT Joins Liger Medical

Improving Women’s Health: MobileODT Joins Liger Medical

| Tagged | Comments Off on Improving Women’s Health: MobileODT Joins Liger Medical

Wasatch Health Announces Structured Capital Fund

Utah Investment Firm Expands to Deliver Flexible Capital to Transformative Healthcare Companies

| Tagged | Comments Off on Wasatch Health Announces Structured Capital Fund

Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains

Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains

| Tagged | Comments Off on Seek Labs Announces Inclusion of Veterinary Diseases in Global Disease Atlas, Accelerating Development of Therapeutics to Bolster Global Protein Supply Chains

Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial

Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial

| Tagged | Comments Off on Nestmedic Selects Curavit Clinical Research as U.S. CRO Partner for Pioneering Prenatal Monitoring Trial

Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions

Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions

| Tagged | Comments Off on Microvascular Therapeutics Celebrates Major Achievements at ASE 2025 Scientific Sessions

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

| Tagged | Comments Off on BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)

Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform

Canary Speech announces it has obtained HITRUST e1 Certification, reinforcing its commitment to cybersecurity related to its voice biomarker technology.

| Tagged | Comments Off on Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform

Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia

Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia

| Tagged | Comments Off on Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia

GE HealthCare’s Economic Impact Across Utah

GE HealthCare’s Economic Impact Across Utah

| Tagged | Comments Off on GE HealthCare’s Economic Impact Across Utah

RefloDx Wins Trans Atlantic Angel Grand Prize

RefloDx Wins Trans Atlantic Angel Grand Prize.

| Tagged | Comments Off on RefloDx Wins Trans Atlantic Angel Grand Prize

bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies

bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies

| Tagged | Comments Off on bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies

DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY

ALPHA-EMITTING RADIOISOTOPE EXPECTED TO PLAY AN ESSENTIAL ROLE IN NEXT-GENERATION TARGETED CANCER THERAPIES

| Tagged | Comments Off on DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY